Skip to main content

Table 3 Pre- and post-vaccination seroprotection rate (percentage of subjects with haemagglutination inhibition titre ≥ 1:40)

From: Safety and immunogenicity of an MF59™-adjuvanted subunit influenza vaccine in elderly Chinese subjects

Viral strain

Vaccination status

Sub/MF59™, % (n = 367)

Subunit, % (n = 187)

A/H1N1

Pre-vaccination

98.4

97.3

 

Post-vaccination

99.7

99.5

A/H3N2

Pre-vaccination

21.5

18.7

 

Post-vaccination

88.0*

72.2

B

Pre-vaccination

2.2

2.1

 

Post-vaccination

35.7

28.3

  1. *P < 0.001 versus the Subunit group
  2. Sub/MF59™, MF59™-adjuvanted subunit influenza vaccine; Subunit, non-adjuvanted subunit influenza vaccine